Leukemia News

The gap in cancer mortality between Black and white individuals shrunk dramatically during the past 3 decades, according to a new report.

In this video, Ghayas C. Issa, MD, assistant professor in the department of leukemia at MD Anderson Cancer Center, discusses how advances in the understanding of prognostic biomarkers may help guide the treatment of AML.

In this video, Ghayas C. Issa, MD, assistant professor in the department of leukemia at MD Anderson Cancer Center, discusses strategies for preventing relapse in patients with AML.

In this video, Ghayas C. Issa, MD, assistant professor in the department of leukemia at MD Anderson Cancer Center, discusses the biggest challenges in AML care today.

In this video, Ghayas C. Issa, MD, assistant professor in the department of leukemia at MD Anderson Cancer Center, discusses emerging and experimental therapies being researched for AML.

In this video, Ghayas C. Issa, MD, assistant professor in the department of leukemia at MD Anderson Cancer Center, discusses the latest advancements in treatment options for acute myeloid leukemia.

More than 20% of patients with cancer participate in some form of clinical study, and that number is considered a “floor” estimate, according to study results published in Journal of Clinical Oncology.

Children conceived via fresh or frozen embryo transfer may have increased risk for acute lymphoblastic leukemia compared with children conceived naturally, according to cohort study results published in JAMA Network Open.

New guidelines for vaccinating adults with solid or hematologic cancers detailed the importance of vaccination optimization, multidisciplinary coordination and vaccination of household members.